Article
COXFA4L2 upregulation preserves residual cytochrome c oxidase activity in COXFA4-related Leigh-like encephalopathy.
Nature communications - 30 May 2026
Falabella Micol, Lopez Calcerrada Sandra, Aref Jana, Gao Jiaze, Macken William L, Pizzamiglio Chiara, Kabiljo Renata, Francavilla Anna Lucia, Gaignard Pauline, Pouzet Antoine, Levy Jonathan, Barcia Giulia, Leighton Jamie K, Chronopoulou Efstathia, Pierre Germaine, Köksal Özgül Riza, Dursun Ali, Halligan Rebecca, Mundy Helen, Raza Alvi Javeria, Sultan Tipu, Craigen William James, Emrick Lisa, Rosenfeld Jill A, Elmakkawy Gehad, Kim JiHye, Gleeson Joseph J, Rad Aboulfazl, Oprea Gabriela, Hussain Maqbool, Rehman Khalil Ur, Riaz Sadia, Taylor Robert W, Procaccio Vincent, Zaki Maha S, Fernandez-Vizarra Erika, Pierri Ciro Leonardo, Hanna Michael G, Houlden Henry, Maroofian Reza, Ugalde Cristina, Taanman Jan-Willem, Pitceathly Robert D S
Abstract excerpt
Primary mitochondrial diseases (PMDs) affect approximately 1 in 4300 individuals and cause early-onset neuromuscular and multisystem dysfunction with reduced lifespan. They result from pathogenic variants in mitochondrial or nuclear DNA that impair oxidative phosphorylation. Cytochrome c oxidase (COX; complex IV) deficiency is a well-established cause of PMD, leading to a broad spectrum of phenotypes. COXFA4...
Topics
- Humans
- Electron Transport Complex IV
- Leigh Disease
- Up-Regulation
- Fibroblasts
- Mitochondrial Diseases
